Connecticut To Receive Share Of GSK Drug Settlement
July 30, 2012
Connecticut is the most recent of 37 states to join the list of beneficiaries from a $3 billion settlement between the federal government and drug manufacturing giant, GlaxoSmithKline (GSK), in regards to allegations of illegal sales and marketing practices. According to Norwalk Plus, the Connecticut Drug Injury settlement will bring the state roughly $11.1 million.
The allegations against GSK arose several years ago after it was discovered that the company was using “off-label” marketing strategies, or pushing the drugs to treat conditions for which they aren’t approved. Further investigation into the company’s sales and marketing departments showed that GSK sales representatives and executives were also involved in re-pricing medications so that doctors who prescribed them would receive “kickback” payments from federal healthcare organizations, such as Medicaid and Medicare.
The claims against the company continued to grow when it was uncovered that GSK had also put two medications onto the market with improper warning labels.
To resolve the allegations, GSK agreed to pay a total of $2 billion in civil damages and penalties to the government as well as another $1 billion in criminal fines.
The Hartford Personal Injury Lawyers with Carter Mario Law Firm would encourage anyone who has suffered negative effects from taking a medication, which was prescribed to you by a doctor for an “off-label” use, to look at your legal options by discussing your case with a knowledgeable attorney.